Association of obesity with prostate specific antigen and prostate specific antigen velocity in healthy young men
- PMID: 18207169
- DOI: 10.1016/j.juro.2007.10.066
Association of obesity with prostate specific antigen and prostate specific antigen velocity in healthy young men
Abstract
Purpose: We examined whether the body mass index and change of weight are associated with the prostate specific antigen level as well as the rate of prostate specific antigen velocity in healthy young Korean men.
Materials and methods: We enrolled in this study 8,176 men who were younger than 51 years and in whom prostate specific antigen was evaluated at least 3 times. Bivariate and multivariate general linear models were used to assess the independent contributions of age, body mass index and prostate specific antigen. Mean prostate specific antigen velocity was compared in the men for different prostate specific antigen ranges, ages, body mass indexes and weight changes using ANOVA tests. Linear logistic regression analysis was used to determine the independent variables related to prostate specific antigen velocity greater than 0 ng/ml per year.
Results: Initial prostate specific antigen decreased in monotonic fashion according to the body mass index category. In the adjusted model the body mass index was a statistically significant variable. The number of men presenting with prostate specific antigen velocity greater than 0 ng/ml per year was significantly higher in those who were older and lower in those who had a greater weight gain (p <0.05 and <0.001, respectively). On multivariate analysis age more than 40 years and a weight gain of more than 5 kg were independent predictive variables that affected prostate specific antigen velocity more than 0 ng/ml per year.
Conclusions: The results of this study show that age and weight changes are associated with substantial differences in prostate specific antigen velocity. Therefore, clinical interpretation of prostate specific antigen velocity may be biased by these factors.
Similar articles
-
The clinical significance in healthy men of the association between obesity related plasma hemodilution and tumor marker concentration.J Urol. 2009 Feb;181(2):567-72; discussion 572-3. doi: 10.1016/j.juro.2008.10.030. Epub 2008 Dec 13. J Urol. 2009. PMID: 19084848
-
Does body mass index affect preoperative prostate specific antigen velocity or pathological outcomes after radical prostatectomy?J Urol. 2007 Jan;177(1):102-6; discussion 106. doi: 10.1016/j.juro.2006.08.097. J Urol. 2007. PMID: 17162013
-
Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase.Cancer. 2006 Jan 15;106(2):320-8. doi: 10.1002/cncr.21603. Cancer. 2006. PMID: 16342294
-
Prostate specific antigen velocity threshold for predicting prostate cancer in young men.J Urol. 2007 Mar;177(3):899-902. doi: 10.1016/j.juro.2006.10.028. J Urol. 2007. PMID: 17296371
-
Prostate-specific Antigen Velocity Risk Count to Discern Significant From Indolent Prostate Cancer.Rev Urol. 2014;16(3):154-6. Rev Urol. 2014. PMID: 25337050 Free PMC article. Review. No abstract available.
Cited by
-
Relationship between insulin resistance, obesity and serum prostate-specific antigen levels in healthy men.Asian J Androl. 2010 May;12(3):400-4. doi: 10.1038/aja.2009.90. Epub 2010 Mar 22. Asian J Androl. 2010. PMID: 20305674 Free PMC article.
-
Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen.Cancer Causes Control. 2020 May;31(5):431-449. doi: 10.1007/s10552-020-01291-3. Epub 2020 Mar 11. Cancer Causes Control. 2020. PMID: 32162172 Free PMC article.
-
Best of the 2008 AUA Annual Meeting: Highlights from the 2008 Annual Meeting of the American Urological Association, May 17-22, 2008, Orlando, FL.Rev Urol. 2008 Spring;10(2):136-56. Rev Urol. 2008. PMID: 18660856 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical